Ask AI
ProCE Banner Activity

Emerging Therapies and Novel Approaches Targeting BCMA in Myeloma

Slideset Download
Download this short summary slideset of key topics in the evolving use of BCMA-targeted therapies for heavily pretreated relapsed/refractory multiple myeloma.

Released: October 23, 2020

Expiration: October 22, 2021

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Celgene

Faculty Disclosure

Primary Author

Natalie S. Callander, MD

Director, Myeloma Clinical and Cellular Therapy Program
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin